Decoding Prostate Cancer: Understanding the Nuances and Busting Myths The recent news surrounding Joe Biden’s prostate cancer diagnosis has sparked a flurry of discussions and, unfortunately, a fair amount of misinformation. As a medical journalist, I’m here to provide clarity on the complexities of prostate cancer, drawing from expert insights to separate fact from fiction. … Read more
Escalating Early-Onset Cancer Rates: What This Means for the Future Understanding the Increase Recent studies have highlighted a concerning trend: the rise of certain cancer types, including breast, colorectal, and thyroid cancers, among individuals under 50 in the United States. Between 2010 and 2019, despite overall cancer incidence and mortality rates remaining stable, early-onset cancers … Read more
The Evolution of Anal Cancer Treatment: A Closer Look at Retifanlimab The landscape of anal cancer treatment is witnessing a significant shift with the recent FDA approval of retifanlimab-dlwr (Zynyz, Incyte) under two new indications. This marks a pivotal development for patients suffering from locally recurrent or metastatic squamous cell anal carcinoma. First-Line Treatment Breakthrough … Read more
Unpacking the Latest Findings in Prostate Cancer Treatment Recent studies, such as the multicenter phase 2 RAVENS trial, shed light on evolving strategies against metastatic prostate cancer. The trial evaluated the efficacy of combining radium-223 dichloride (Ra223) with metastasis-directed stereotactic ablative radiotherapy (SABR) in treating bone-only oligometastatic castration-sensitive prostate cancer. Though the combination showed no … Read more
Adrenal Cortical Oncocytic Neoplasms: A Silent Challenge Adrenal Cortical Oncocytic Neoplasms (ACON) are rare adrenal gland tumors that continue to perplex medical experts due to their atypical presentations. A recent Swiss case highlights the complexities involved in diagnosing and managing these conditions, particularly when they disrupt metabolic systems and mental health. Understanding the Atypical Presentations … Read more
Revolutionizing Prostate Cancer Diagnosis: A Multidisciplinary Approach The landscape of prostate cancer diagnosis is on the cusp of a transformative change, driven by the collaborative efforts of key pathological societies. The Genitourinary Pathology Society (GUPS) and the International Society of Urological Pathology (ISUP) recently published a white paper in European Urology, calling for significant improvements … Read more
Fertility Preservation in Cancer Care: New Horizons Advancements in the field of oncology are not only improving survival rates but also heightening awareness of the long-term effects of cancer treatments, notably on fertility. The American Society of Clinical Oncology (ASCO) has recently released updated guidelines emphasizing fertility preservation in cancer treatment, heralding a new era … Read more
Understanding the Rising Challenge of Uterine Cancer in the USA The United States faces a growing challenge with uterine cancer, as highlighted by the 2025 Cancer Statistics. With over 69,000 new cases predicted annually, this cancer stands out for its increasing mortality rates and the widening Black-White mortality disparity. Why The Statistics Are Worsening The … Read more
Understanding Interval Breast Cancers: An Emerging Trend In the realm of breast cancer research, a new study from Sweden highlights an intriguing trend: while the overall incidence of interval breast cancers diagnosed in screened patients has increased over an almost 30-year period, the proportion of interval cancers versus screen-detected cancers has remained steady at about … Read more
The Evolving Role of Risk-Reduction Surgery in Non-BRCA Gene Mutations As the landscape of genetic testing advances, so too does our understanding of cancer prevention, particularly for those with non-BRCA gene mutations. Recent research presented at the 2025 ANNALS of the USCAP reveals crucial insights into the efficacy of prophylactic surgeries beyond traditional BRCA1 and … Read more